CCM
PODD icon

Camber Capital Management’s Insulet PODD Stock Holding History

Camber Capital Management’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-245,000
Closed -$6.35M – 52
2015
Q3 		$6.35M Buy
+245,000
New +$7.43M 0.54% 35

Other funds holding PODD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
VM
Valinor Management New York $32.2M AUM 44.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Camber Capital Management's PODD Position: Q4 2015 in Review

Camber Capital Management sold out of Insulet (PODD) in Q4 2015, closing a stake of 245,000 shares — an estimated $6.35M sold.

Camber Capital Management first reported a position in PODD in Q3 2015 and held it in 1 quarter. The position peaked at $6.35M in Q3 2015. 162 funds tracked by Wall St. Rank hold PODD as of Q4 2015.

  • Camber Capital Management reported no remaining Insulet position as of Q4 2015 after selling out during the quarter.
  • Camber Capital Management sold 245,000 Insulet shares in Q4 2015, an estimated $6.35M.
  • Camber Capital Management first reported a position in Insulet in Q3 2015 and held it in 1 quarter.
  • Camber Capital Management's Insulet position peaked at $6.35M in Q3 2015.
  • 162 funds tracked by Wall St. Rank held Insulet as of Q4 2015.

Based on Camber Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.